VOLTAREN Safety Questions, VOLTAREN Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about VOLTAREN. Our extensive database of VOLTAREN adverse events and VOLTAREN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about VOLTAREN
VOLTAREN Safety Reports
Total VOLTAREN reports: 366.VOLTAREN FDA safety alerts: No.
Reported deaths: 42 Reported hospitalizations: 177.
Take VOLTAREN Side Effects Survey or Share Your VOLTAREN Story. VOLTAREN Usage.
Showing 1-75 of 366 Next >
Consumer or non-health professional from BRAZIL reported VOLTAREN problem on Apr 05, 2007. Female patient was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: muscle disorder, muscle necrosis, skin necrosis. VOLTAREN dosage: 75 MG, UNK. Patient recovered.VOLTAREN problem was reported by a Consumer or non-health professional from BRAZIL on Apr 05, 2007. Female patient was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: dyskinesia, hypoaesthesia, injection site necrosis, pain in extremity. VOLTAREN dosage: 75 MG, UNK. Patient recovered.
Consumer or non-health professional from CHINA reported VOLTAREN problem on Apr 09, 2007. Male patient, 39 years of age, weighting 202.8 lb, was diagnosed with arthralgia and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: blood urine present, henoch-schonlein purpura, petechiae, protein urine present. VOLTAREN dosage: 25 MG/DAY. Patient recovered.
VOLTAREN problem was reported by a Consumer or non-health professional from BRAZIL on Apr 10, 2007. Female patient, 63 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site necrosis, injection site pain, refusal of treatment by patient, scar, skin discomfort, subcutaneous abscess, wound debridement. VOLTAREN dosage: 75 MG, UNK. Patient recovered.
Consumer or non-health professional from BRAZIL reported VOLTAREN problem on Apr 10, 2007. Female patient, 31 years of age, was diagnosed with renal colic and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: hypokinesia, injection site anaesthesia, injection site discolouration, injection site necrosis, injection site pain, muscle disorder, scar, skin necrosis, syncope. VOLTAREN dosage: 75 MG, UNK. Patient recovered.
VOLTAREN problem was reported by a Consumer or non-health professional from BRAZIL on Apr 10, 2007. Female patient, 44 years of age, was diagnosed with renal colic and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site necrosis, injection site pain, injection site swelling, scar, skin discomfort, subcutaneous abscess, wound debridement. VOLTAREN dosage: 75 MG, UNK. Patient recovered.
Consumer or non-health professional from BRAZIL reported VOLTAREN problem on Apr 10, 2007. Female patient, 57 years of age, was diagnosed with musculoskeletal pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: hypokinesia, injection site discolouration, injection site movement impairment, injection site necrosis, injection site pain, muscle necrosis, paraesthesia, scar, skin disorder. VOLTAREN dosage: 75 MG/DAY. Patient was hospitalized. Patient recovered.
VOLTAREN problem was reported by a Physician from BELGIUM on Apr 12, 2007. Male patient, 40 years of age, was diagnosed with back pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: paralysis, paresis, sciatic nerve injury. VOLTAREN dosage: 75MG INTRAMUSCULAR INJECTION. Patient recovered.
Consumer or non-health professional from FRANCE reported VOLTAREN problem on Apr 10, 2007. Female patient, 71 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: joint destruction, nuclear magnetic resonance imaging abnormal, osteitis, osteonecrosis, pain in extremity, red blood cell sedimentation rate increased, white blood cell count increased, wound secretion, wound sepsis. VOLTAREN dosage: 75 MG, QD. During the same period patient was treated with ENBREL, ARAVA, CORTANCYL, ESOMEPRAZOLE MAGNESIUM. Patient was hospitalized. Patient recovered.
VOLTAREN problem was reported by a Pharmacist from JAPAN on Apr 10, 2007. Male patient, 76 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: axillary pain, rhabdomyolysis. VOLTAREN dosage: unknown. Patient recovered.
Consumer or non-health professional from JAPAN reported VOLTAREN problem on Apr 19, 2007. Male patient, 65 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute, sepsis, shock. VOLTAREN dosage: unknown. Patient died on 01/01/2002.
VOLTAREN problem was reported by a Consumer or non-health professional from BRAZIL on Apr 16, 2007. Male patient, 22 years of age, was diagnosed with back pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: injection site haemorrhage, injection site swelling. VOLTAREN dosage: 75 MG, ONCE/SINGLE. Patient recovered.
Pharmacist from JAPAN reported VOLTAREN problem on Apr 18, 2007. Female patient, 85 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, hepatitis b, jaundice, vomiting. VOLTAREN dosage: unknown. Patient recovered.
VOLTAREN problem was reported by a Consumer or non-health professional from JAPAN on Apr 18, 2007. Male patient, 55 years of age, was diagnosed with pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: eosinophilic pneumonia. VOLTAREN dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported VOLTAREN problem on Apr 18, 2007. Female patient, 74 years of age, was diagnosed with pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: abscess drainage, dural tear, extradural abscess, gastrointestinal haemorrhage, intervertebral discitis, osteomyelitis, pulmonary hypertension, spinal column stenosis, spinal laminectomy. VOLTAREN dosage: unknown. During the same period patient was treated with CLONIDINE, COTENSIN, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE, NEXIUM, LIPITOR, LYRICA. Patient was hospitalized. Patient recovered.
VOLTAREN problem was reported by a Consumer or non-health professional from on Apr 19, 2007. Female patient, 25 years of age, was diagnosed with dysmenorrhoea and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, antigliadin antibody positive, depressed level of consciousness, dizziness, dyspnoea, flushing, hypotension, mood altered, skin test positive. VOLTAREN dosage: unknown. During the same period patient was treated with LOXONIN. Patient recovered.
Consumer or non-health professional from SWEDEN reported VOLTAREN problem on Apr 13, 2007. Female patient, 32 years of age, was diagnosed with torticollis and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: blister, hypersensitivity, obstructive airways disorder, swollen tongue. VOLTAREN dosage: unknown. Patient recovered.
VOLTAREN problem was reported by a Physician from FRANCE on Apr 19, 2007. Female patient, 55 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, haematochezia. VOLTAREN dosage: 75 MG/DAY. Patient recovered.
Physician from FRANCE reported VOLTAREN problem on Apr 19, 2007. Female patient, 55 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal mucosal disorder, haematochezia. VOLTAREN dosage: unknown. Patient recovered.
VOLTAREN problem was reported by a Consumer or non-health professional from FRANCE on Apr 18, 2007. Female patient, 94 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: back pain, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, disorientation, dysphagia, haematemesis, haemoglobin decreased, hypotension. VOLTAREN dosage: 150 MG/DAY. During the same period patient was treated with OMEPRAZOLE, VASTAREL, TEMESTA, FUROSEMIDE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported VOLTAREN problem on Apr 19, 2007. Male patient, 75 years of age, was diagnosed with pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: gait disturbance, impaired healing, incisional drainage, insomnia, pain, wound secretion. VOLTAREN dosage: 100 MG, QD. During the same period patient was treated with TRAMADOL, SERESTA, ALLOPURINOL. Patient recovered.
VOLTAREN problem was reported by a Pharmacist from CANADA on Apr 23, 2007. Male patient, 41 years of age, was diagnosed with pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: hallucination, headache, psychotic disorder, visual disturbance. VOLTAREN dosage: 75 MG, BID. During the same period patient was treated with BACLOFEN, CELEXA, PANTOPRAZOLE, ATIVAN, RISPERIDONE, SEROQUEL, TORADOL. Patient recovered.
Pharmacist from JAPAN reported VOLTAREN problem on Apr 25, 2007. Male patient, 69 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: body temperature decreased, cold sweat, depressed level of consciousness, shock. VOLTAREN dosage: unknown. Patient recovered.
VOLTAREN problem was reported by a Consumer or non-health professional from JAPAN on Apr 27, 2007. Male patient, 65 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, condition aggravated, malaise, nausea, pancreatitis acute, pyrexia, sepsis, shock. VOLTAREN dosage: unknown. Patient died on 01/01/2002.
Pharmacist from reported VOLTAREN problem on Apr 19, 2007. Female patient was diagnosed with headache and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, dizziness, feeling hot, nausea. VOLTAREN dosage: 75 MG/DAY. During the same period patient was treated with ADEFURONIC, DEPAKENE, CLOBAZAM. Patient recovered.
VOLTAREN problem was reported by a Physician from FRANCE on May 02, 2007. Female patient, 55 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal mucosal disorder, haematochezia. VOLTAREN dosage: unknown. Patient recovered.
Consumer or non-health professional from DENMARK reported VOLTAREN problem on May 01, 2007. Female patient, 73 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, oedema. VOLTAREN dosage: unknown. Patient was hospitalized. Patient recovered.
VOLTAREN problem was reported by a Physician from JAPAN on May 08, 2007. Male patient, 41 years of age, weighting 132.3 lb, was diagnosed with pyrexia, brain stem haemorrhage, vomiting, upper gastrointestinal haemorrhage, brain oedema and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood calcium increased, blood creatine phosphokinase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood pressure decreased, blood urea increased. VOLTAREN dosage: 75 MG/DAY. During the same period patient was treated with ADONA, TRANSAMIN, PRIMPERAN, GASTER, GLYCEOL. Patient was hospitalized. Patient died on 02/18/2007.
Pharmacist from UNITED KINGDOM reported VOLTAREN problem on May 02, 2007. Female patient, 62 years of age, was diagnosed with pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, dyspepsia, vomiting. VOLTAREN dosage: unknown. During the same period patient was treated with OMEPRAZOLE, DURAGESIC, PARACETAMOL. Patient was hospitalized. Patient recovered.
VOLTAREN problem was reported by a Consumer or non-health professional from AUSTRALIA on May 03, 2007. Female patient, 80 years of age, was diagnosed with epicondylitis and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: glossodynia, swollen tongue. VOLTAREN dosage: unknown. During the same period patient was treated with ASPIRIN, CLARITIN, FISH OIL, GLUCOSAMINE. Patient recovered.
Consumer or non-health professional from JAPAN reported VOLTAREN problem on May 07, 2007. Male patient, 55 years of age, was diagnosed with pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: biopsy lung abnormal, blood lactate dehydrogenase increased, chest x-ray abnormal, cough, dyspnoea, eosinophil count increased, eosinophilic pneumonia, haemoglobin decreased, lymphocyte count decreased. VOLTAREN dosage: 50 MG, UNK. Patient recovered.
VOLTAREN problem was reported by a Consumer or non-health professional from AUSTRALIA on May 08, 2007. Male patient, 79 years of age, was diagnosed with neck injury and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site pain, application site rash, application site scab, application site vesicles. VOLTAREN dosage: unknown. Patient recovered.
Consumer or non-health professional from SPAIN reported VOLTAREN problem on May 08, 2007. Male patient, 72 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, rectal haemorrhage, sigmoidoscopy abnormal. VOLTAREN dosage: 50 MG, BID. During the same period patient was treated with NUROFEN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
VOLTAREN problem was reported by a Pharmacist from JAPAN on May 08, 2007. Female patient, 49 years of age, was diagnosed with herpes zoster and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock. VOLTAREN dosage: unknown. During the same period patient was treated with VALTREX. Patient recovered.
Pharmacist from JAPAN reported VOLTAREN problem on May 08, 2007. Female patient, 49 years of age, was diagnosed with herpes zoster and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock. VOLTAREN dosage: unknown. During the same period patient was treated with VALTREX. Patient recovered.
VOLTAREN problem was reported by a Pharmacist from JAPAN on May 10, 2007. Female patient was diagnosed with headache and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, dizziness, feeling hot, nausea. VOLTAREN dosage: 75 MG/DAY. During the same period patient was treated with ADEFURONIC, DEPAKENE, CLOBAZAM. Patient recovered.
Consumer or non-health professional from BRAZIL reported VOLTAREN problem on May 10, 2007. Female patient, 66 years of age, was diagnosed with hypertension and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: burn debridement, chills, cough, dyspnoea, inflammation, oedema peripheral, pain, pyrexia, shock. VOLTAREN dosage: unknown. During the same period patient was treated with RENITEC, PURAN T, VALIUM, SIMVASTATIN, HYDROCHLOROTHIAZIDE, NOVALGINA, ORBINOL. Patient recovered.
VOLTAREN problem was reported by a Consumer or non-health professional from NORWAY on May 14, 2007. Female patient, 90 years of age, was diagnosed with pain in extremity and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, dehydration, haematemesis, peritonitis, renal failure, respiratory failure. VOLTAREN dosage: unknown. Patient died on 04/01/2007.
Pharmacist from JAPAN reported VOLTAREN problem on May 08, 2007. Male patient, 62 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: completed suicide. VOLTAREN dosage: unknown. Patient died on 05/08/2007.
VOLTAREN problem was reported by a Physician from JAPAN on May 15, 2007. Female patient, 49 years of age, was diagnosed with herpes zoster and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, blood glucose increased, dyspnoea, feeling hot, stridor. VOLTAREN dosage: unknown. During the same period patient was treated with VALTREX, NEUER, CYANOCOBALAMIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from BRAZIL reported VOLTAREN problem on May 15, 2007. Female patient, 66 years of age, was diagnosed with hypertension and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: anorectal disorder, burn debridement, chills, cough, dyspnoea, inflammation, oedema peripheral, pain, pyrexia. VOLTAREN dosage: unknown. During the same period patient was treated with RENITEC, PURAN T, VALIUM, SIMVASTATIN, HYDROCHLOROTHIAZIDE, NOVALGINA, ORBINOL. Patient recovered.
VOLTAREN problem was reported by a Physician from JAPAN on May 15, 2007. Male patient, 16 years of age, was diagnosed with pyrexia, nasopharyngitis, viral infection, influenza like illness and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, c-reactive protein increased, glucose-6-phosphate dehydrogenase deficiency, haematocrit decreased, haematuria. VOLTAREN dosage: 50 MG/DAY. During the same period patient was treated with CLARITHROMYCIN, SELBEX, PL GRAN, PANSPORIN, RELENZA, CALONAL, ALPINYL. Patient was hospitalized. Patient recovered.
Pharmacist from JAPAN reported VOLTAREN problem on May 14, 2007. Male patient, 71 years of age, weighting 136.7 lb, was diagnosed with osteoarthritis, hyperlipidaemia, hypertension and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, bronchoalveolar lavage abnormal, cryptogenic organising pneumonia, dyspnoea, gamma-glutamyltransferase increased. VOLTAREN dosage: 25 MG/DAY. During the same period patient was treated with LIPOVAS, NORVASC, FLUITRAN, INHIBACE. Patient was hospitalized. Patient recovered.
VOLTAREN problem was reported by a Consumer or non-health professional from JAPAN on May 15, 2007. Male patient, 24 years of age, was diagnosed with abdominal pain upper and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, abdominal tenderness, biopsy colon abnormal, computerised tomogram abnormal, endoscopy upper gastrointestinal tract abnormal, enteritis, erosive duodenitis, inflammation, localised oedema. VOLTAREN dosage: unknown. During the same period patient was treated with PROTON PUMP INHIBITORS. Patient was hospitalized. Patient recovered.
Pharmacist from JAPAN reported VOLTAREN problem on May 16, 2007. Male patient, 76 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: axillary pain, rhabdomyolysis. VOLTAREN dosage: unknown. During the same period patient was treated with MEVALOTIN, LOXONIN. Patient recovered.
VOLTAREN problem was reported by a Pharmacist from JAPAN on May 16, 2007. Male patient, 71 years of age, weighting 136.7 lb, was diagnosed with osteoarthritis, hyperlipidaemia, hypertension and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, bronchoalveolar lavage abnormal, cryptogenic organising pneumonia, dyspnoea, gamma-glutamyltransferase increased, lymphocyte stimulation test positive. VOLTAREN dosage: 25 MG/DAY. During the same period patient was treated with LIPOVAS, NORVASC, FLUITRAN, INHIBACE. Patient was hospitalized. Patient recovered.
Pharmacist from JAPAN reported VOLTAREN problem on May 16, 2007. Female patient, 30 years of age, was diagnosed with headache and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, dizziness, feeling hot, nausea. VOLTAREN dosage: 75 MG/DAY. During the same period patient was treated with ADEFURONIC, DEPAKENE, CLOBAZAM. Patient recovered.
VOLTAREN problem was reported by a Physician from MALTA on May 22, 2007. Male patient was diagnosed with analgesic effect, diabetes mellitus and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: abscess, abscess drainage, soft tissue necrosis. VOLTAREN dosage: 1 X 75MG/3ML INJECTION. During the same period patient was treated with INSULIN. Patient recovered.
Consumer or non-health professional from UNITED STATES reported VOLTAREN problem on Mar 28, 2006. Female patient was diagnosed with back pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: renal failure. VOLTAREN dosage: 50 TO 100 MG TID. Patient recovered.
VOLTAREN problem was reported by a Physician from UNITED STATES on Feb 16, 2007. Female patient, 37 years of age, was diagnosed with eye laser surgery and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: keratitis. VOLTAREN dosage: unknown. During the same period patient was treated with PROPARACAINE, ZYMAR, FLUOROMETHOLONE, BALANCED SALT SOLUTION. Patient recovered.
Physician from UNITED STATES reported VOLTAREN problem on Feb 16, 2007. Male patient, 41 years of age, was diagnosed with eye laser surgery and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: keratitis. VOLTAREN dosage: unknown. During the same period patient was treated with PROPARACAINE, ZYMAR, FLUOROMETHOLONE, BALANCED SALT SOLUTION CALCIUM CHLORIDE DIHYDRATE. Patient recovered.
VOLTAREN problem was reported by a Physician from UNITED STATES on Feb 16, 2007. Male patient, 60 years of age, was diagnosed with eye laser surgery and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: keratitis. VOLTAREN dosage: unknown. During the same period patient was treated with PROPARACAINE, ZYMAR, FLUOROMETHOLONE, BALANCED SALT SOLUTION. Patient recovered.
Health Professional from UNITED STATES reported VOLTAREN problem on May 23, 2007. Female patient, 67 years of age, weighting 132.3 lb, was diagnosed with rheumatoid arthritis and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hepatitis b, hepatorenal syndrome, jaundice, malaise, oedema, urine output decreased, weight increased. VOLTAREN dosage: 25 MG, QD. During the same period patient was treated with ISCOTIN, ETANERCEPT, PROGRAF, PREDONINE, HYPEN, METHOTREXATE, FOLIAMIN, KOLANTYL. Patient was hospitalized. Patient recovered.
VOLTAREN problem was reported by a Consumer or non-health professional from JAPAN on May 23, 2007. Female patient, 16 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: eosinophilic pneumonia, suicide attempt. VOLTAREN dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported VOLTAREN problem on May 23, 2007. Male patient, 89 years of age, was diagnosed with musculoskeletal pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: pruritus, skin ulcer. VOLTAREN dosage: unknown. Patient recovered.
VOLTAREN problem was reported by a Consumer or non-health professional from JAPAN on May 30, 2007. Male patient, child 11 years of age, weighting 70.55 lb, was diagnosed with antipyresis, antibiotic prophylaxis and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood creatinine increased, blood fibrinogen decreased, blood lactate dehydrogenase increased, blood ph increased, blood urea increased. VOLTAREN dosage: 50 MG/DAY. During the same period patient was treated with PREDONINE, BUFFERIN, SULPYRINE, KASHILON, CEFAZOLIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported VOLTAREN problem on May 25, 2007. Female patient, 42 years of age, was diagnosed with rheumatoid arthritis and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: infertility female. VOLTAREN dosage: 100MG DAILY. During the same period patient was treated with PREDNISOLONE. Patient recovered.
VOLTAREN problem was reported by a Consumer or non-health professional from FRANCE on May 29, 2007. Female patient, 92 years of age, weighting 92.59 lb, was diagnosed with muscle strain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, hyponatraemia, iron deficiency anaemia, rash erythematous, rash macular, rash papular, vascular purpura. VOLTAREN dosage: unknown. During the same period patient was treated with STABLON, XALATAN, COSOPT, DIFFU K, LORAZEPAM, PARIET, CACIT D, DAFALGAN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported VOLTAREN problem on May 29, 2007. Male patient, 74 years of age, was diagnosed with sciatica and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, bundle branch block right, gamma-glutamyltransferase increased, hypertension, nausea, nephroangiosclerosis, oxygen saturation decreased, petit mal epilepsy, vascular resistance systemic increased. VOLTAREN dosage: 50 MG, TID. During the same period patient was treated with INIPOMP, LAMALINE, METHOCARBAMOL, DIAMICRON, TENORMIN, ALLOPURINOL, TRIATEC. Patient was hospitalized. Patient recovered.
VOLTAREN problem was reported by a Pharmacist from on May 29, 2007. Female patient was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: urinary retention. VOLTAREN dosage: 50 MG/DAY. Patient recovered.
Consumer or non-health professional from JAPAN reported VOLTAREN problem on May 30, 2007. Male patient, 35 years of age, weighting 141.1 lb, was diagnosed with arthralgia, prophylaxis against gastrointestinal ulcer, hyperthermia and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, eosinophil count increased, erythema, gamma-glutamyltransferase increased, lymphocyte count decreased, pyrexia, rash papular, rash pruritic. VOLTAREN dosage: 37.5 MG, BID. During the same period patient was treated with SELBEX, ADEFURONIC. Patient was hospitalized. Patient recovered.
VOLTAREN problem was reported by a Consumer or non-health professional from JAPAN on June 07, 2007. Male patient, child 11 years of age, weighting 70.55 lb, was diagnosed with antipyresis, antibiotic prophylaxis, respiratory failure and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood creatinine increased, blood fibrinogen decreased, blood lactate dehydrogenase increased, blood ph increased, blood urea increased. VOLTAREN dosage: 50 MG, 5QD. During the same period patient was treated with PREDONINE, BUFFERIN, SULPYRINE, KASHILON, CEFAZOLIN, METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from BRAZIL reported VOLTAREN problem on May 31, 2007. Female patient, 66 years of age, was diagnosed with hypertension and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: anorectal disorder, burn debridement, chills, cough, dyspnoea, inflammation, oedema peripheral, pain, pyrexia. VOLTAREN dosage: unknown. During the same period patient was treated with RENITEC, PURAN T, VALIUM, SIMVASTATIN, HYDROCHLOROTHIAZIDE, NOVALGINA, ORBINOL. Patient was hospitalized. Patient recovered.
VOLTAREN problem was reported by a Consumer or non-health professional from JAPAN on June 04, 2007. Female patient, 16 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, body temperature increased, eosinophil count increased, eosinophilic pneumonia, heart rate increased, intentional overdose, life support, lymphocyte stimulation test positive. VOLTAREN dosage: unknown. Patient was hospitalized. Patient recovered.
Pharmacist from JAPAN reported VOLTAREN problem on June 07, 2007. Female patient was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, hepatic enzyme increased, hepatitis fulminant. VOLTAREN dosage: unknown. Patient recovered.
VOLTAREN problem was reported by a Physician from GERMANY on June 06, 2007. Female patient, 17 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: gamma-glutamyltransferase increased, renal failure acute, transaminases increased. VOLTAREN dosage: unknown. Patient was hospitalized. Patient recovered.
Health Professional from AUSTRIA reported VOLTAREN problem on May 04, 2007. Male patient, 51 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, aspiration tracheal, intentional overdose, mendelson's syndrome, rhabdomyolysis, suicide attempt. VOLTAREN dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, DIPYRIDAMOLE. Patient was hospitalized. Patient recovered.
VOLTAREN problem was reported by a Consumer or non-health professional from AUSTRALIA on June 12, 2007. Female patient, 29 years of age, was diagnosed with pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, eyelid oedema, respiratory distress, tachycardia. VOLTAREN dosage: 100 MG, ONCE/SINGLE. Patient recovered.
Health Professional from SPAIN reported VOLTAREN problem on June 07, 2007. Male patient, 41 years of age, was diagnosed with rib fracture, migraine and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: chest pain, migraine, sternal fracture. VOLTAREN dosage: 50 MG/DAY. During the same period patient was treated with ACETAMINOPHEN, MALTAX, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
VOLTAREN problem was reported by a Consumer or non-health professional from AUSTRALIA on June 12, 2007. Female patient, 26 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: circulatory collapse, hypotension, lip swelling, paraesthesia. VOLTAREN dosage: unknown. Patient recovered.
Physician from UNITED KINGDOM reported VOLTAREN problem on June 08, 2007. Female patient was diagnosed with abdominal pain upper and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, injection site anaesthesia, male sexual dysfunction, pain in extremity. VOLTAREN dosage: 50MG / DAY. Patient recovered.
VOLTAREN problem was reported by a Pharmacist from BRAZIL on June 11, 2007. Female patient, 55 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: injection site erythema, injection site irritation, injection site necrosis, injection site pain, injection site scab, plastic surgery, poor quality sleep. VOLTAREN dosage: unknown. Patient recovered.
Physician from FRANCE reported VOLTAREN problem on June 04, 2007. Female patient, 48 years of age, was diagnosed with back pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, injection site discolouration, injection site fibrosis, injection site reaction. VOLTAREN dosage: 75 MG, UNK. During the same period patient was treated with COLTRAMYL. Patient recovered.
VOLTAREN problem was reported by a Health Professional from ITALY on June 11, 2007. Male patient, 35 years of age, was diagnosed with renal colic and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, back pain, nausea, pyelonephritis acute, vomiting. VOLTAREN dosage: 100 MG/DAY. During the same period patient was treated with AULIN. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported VOLTAREN problem on June 05, 2007. Female patient, 55 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, haematochezia, rectal haemorrhage. VOLTAREN dosage: 75 MG/DAY. Patient recovered.
Showing 1-75 of 366 Next >
This
drug has an active FDA Safety Alert